モルヒネ薬の世界市場レポート 2025年

モルヒネ薬市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.5％で、299億9,000万米ドルに成長します。予測期間における成長の背景には、がん患者の増加、疼痛疾患の有病率の増加、緩和ケアに対する意識の高まり、慢性疾患の有病率の上昇、オピオイドの使用増加などがあります。予測期間における主な動向としては、薬剤製剤の技術的進歩、デジタルヘルスソリューションの統合、技術の統合、提携・パートナーシップ、埋め込み型医療機器などが挙げられます。

慢性疼痛疾患の増加は、今後数年間のモルヒネ薬市場の拡大を牽引すると予想されます。高齢化、肥満率の増加、座りっぱなしのライフスタイル、精神衛生上の課題、環境の影響など、さまざまな要因により、傷害や疾病を示す複雑で持続的な不快感である慢性疼痛は、世界の健康上の重大な問題となっています。モルヒネは、鎮痛効果が高く、個々の患者のニーズに合わせることができるため、慢性疼痛の管理において重要な役割を果たしています。これによって生活の質が向上し、慢性疼痛を抱える人が常に強い痛みを感じることなく、よりよく機能できるようになります。例えば、2021年5月現在、カナダ政府によると、2025年までに最大830万人のカナダ人が慢性疼痛を経験し、2030年までに900万人に増加すると予想されています。したがって、慢性疼痛の有病率の上昇がモルヒネ医薬品市場の成長を後押ししています。

モルヒネ製剤市場の主要企業は、治療の選択肢を増やすために硫酸モルヒネ注射剤の開発に注力しています。硫酸モルヒネ注射剤は強力なオピオイド鎮痛薬で、激しい疼痛の管理に使用されます。アヘン由来で、脳や脊髄のオピオイド受容体に結合して作用し、痛みの知覚や情動反応を変化させる。例えば、米国の製薬・医療機器企業であるHospira社は、他の治療法では不十分な場合にオピオイド鎮痛剤を必要とする重度の疼痛管理に適応するオピオイド作動薬である硫酸モルヒネ注を発売しました。モルヒネ硫酸塩注射液には、静脈内投与、硬膜外投与、髄腔内投与用の防腐剤無添加バージョンなど、さまざまな強さと剤形があります。添付文書では、中毒、乱用、誤用などの関連リスクと、使用による重篤で生命を脅かす可能性のある影響が強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界モルヒネ薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のモルヒネ薬市場：成長率分析
• 世界のモルヒネ薬市場の実績：規模と成長, 2019-2024
• 世界のモルヒネ薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界モルヒネ薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のモルヒネ薬市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• オーラル
• その他の剤形
• 世界のモルヒネ薬市場流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のモルヒネ薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 緩和ケア
• 下痢止め
• 麻酔
• 風邪と咳止め
• その他の用途
• 世界のモルヒネ薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 外来手術センター
• その他のエンドユーザー
• 世界のモルヒネ薬市場、注射剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モルヒネ硫酸塩注射液
• 塩酸モルヒネ注射液
• モルヒネ徐放性注射剤
• 世界のモルヒネ薬市場、口腔のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口錠（即放性、徐放性）
• 経口液またはシロップ
• 経口カプセル（徐放性カプセル）
• 世界のモルヒネ薬市場その他の剤形のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直腸坐剤
• 経皮パッチ
• 舌下錠またはフィルム

第7章 地域別・国別分析

• 世界のモルヒネ薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のモルヒネ薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• モルヒネ薬市場：競合情勢
• モルヒネ薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Rusan Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Daiichi Sankyo Company Limited
• Sandoz AG
• Viatris Inc.
• Dr. Reddy's Laboratories Ltd.
• Apotex Inc.
• Hikma Pharmaceuticals PLC
• Endo Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.
• Johnson Matthey Fine Chemicals
• Fresenius Kabi USA LLC
• Delpharm SaS
• Alvogen Inc.
• Mallinckrodt Pharmaceuticals
• Lannett Company
• Mayne Pharma Group Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• モルヒネ薬市場2029：新たな機会を提供する国
• モルヒネ薬市場2029：新たな機会を提供するセグメント
• モルヒネ薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Morphine drugs encompass a category of medications containing morphine, a potent opioid analgesic derived from the opium poppy plant. These drugs are employed for alleviating moderate to severe pain, typically post-surgical procedures, injuries, or in the management of conditions such as cancer.

The primary dosage forms of morphine drugs include injectable, oral, and other formulations. Injectable forms are designed for administration via injection, delivering rapid effects by bypassing the digestive system. These drugs are distributed through channels such as hospital pharmacies, retail pharmacies, and online platforms, serving various purposes such as pain management, palliative care, diarrhea suppression, anesthesia, cold and cough relief, among others. They are utilized by diverse end users including hospitals, clinics, ambulatory surgical centers, and others.

The morphine drugs market research report is one of a series of new reports from The Business Research Company that provides morphine drugs market statistics, including the morphine drugs industry's global market size, regional shares, competitors with a morphine drugs market share, detailed morphine drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the morphine drugs industry. This morphine drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The morphine drugs market size has grown strongly in recent years. It will grow from $21.82 billion in 2024 to $23.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rise in the number of cancer cases, rise in prevalence of orthopedic diseases, rise in number of surgical procedures, rise in the aging population, and a rise in healthcare expenditure.

The morphine drugs market size is expected to see strong growth in the next few years. It will grow to $29.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to an increase in cancer cases, increasing prevalence of pain conditions, growing awareness of palliative care, rising prevalence of chronic disorders, and increased use of opioids. Major trends in the forecast period include technological advancements in drug formulation, integration of digital health solutions, integration of technology, collaborations and partnerships, and implantable medical devices.

The rise in chronic pain conditions is expected to drive the expansion of the morphine drugs market in the coming years. Chronic pain, a complex and persistent discomfort signaling injury or illness, has become a significant global health concern due to various factors such as aging populations, increasing obesity rates, sedentary lifestyles, mental health challenges, and environmental influences. Morphine plays a crucial role in managing chronic pain because of its high effectiveness in pain relief and its ability to be tailored to individual patient needs. This improves quality of life and allows individuals with chronic pain to function better without constant severe pain. For example, as of May 2021, according to the Government of Canada, up to 8.3 million Canadians may experience chronic pain by 2025, with an expected increase to 9.0 million by 2030. Hence, the rising prevalence of chronic pain conditions is fueling the growth of the morphine drug market.

Leading companies in the morphine drug market are focusing on developing morphine sulfate injection to enhance medical treatment options. Morphine sulfate injection is a potent opioid analgesic used for managing severe pain. Derived from opium, it acts by binding to opioid receptors in the brain and spinal cord, altering pain perception and emotional responses. For instance, Hospira, a US-based pharmaceutical and medical device company, introduced Morphine Sulfate Injection, an opioid agonist indicated for severe pain management requiring an opioid analgesic when other treatments are insufficient. It comes in various strengths and formulations, including a preservative-free version for intravenous, epidural, or intrathecal use. The labeling emphasizes associated risks such as addiction, abuse, and misuse, along with serious and potentially life-threatening effects from its use.

In January 2024, Taiwan-based pharmaceutical company CDMO Bora Pharmaceuticals Inc. acquired Upsher-Smith Laboratories Inc. for $210 million. This acquisition is aimed at strengthening Bora's presence in the generics market, potentially expanding its product range, enhancing manufacturing capacity, fostering innovation, and exploring new geographic markets. Upsher-Smith Laboratories Inc., a US-based pharmaceutical company, specializes in manufacturing morphine drugs.

Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA

North America was the largest region in the morphine drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the morphine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the morphine drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The morphine drugs market consists of sales of morphine sulfate, Roxanol oral solution, Kadian capsules, morphine injections, and Avinza capsules. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Morphine Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on morphine drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for morphine drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The morphine drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage form: Injectable; Oral; Other Dosage Forms
• 2) By Distribution channels: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 3) By Applications: Pain Management; Palliative Care; Diarrhea Suppressant; Anesthesia; Cold And Cough Suppressant; Other Applications
• 4) By End Users: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Injectable: Morphine Sulfate Injection; Morphine Hydrochloride Injection; Morphine Extended Release Injection
• 2) By Oral: Oral Tablets ( Immediate-Release, Extended-Release); Oral Solution Or syrup; Oral Capsules (Extended-Release Capsules)
• 3) By Other Dosage Forms: Rectal Suppositories; Transdermal Patches; Sublingual Tablets Or Films
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Rusan Pharma Ltd.; Johnson & Johnson; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Morphine Drugs Market Characteristics

3. Morphine Drugs Market Trends And Strategies

4. Morphine Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Morphine Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Morphine Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Morphine Drugs Market Growth Rate Analysis
• 5.4. Global Morphine Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Morphine Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Morphine Drugs Total Addressable Market (TAM)

6. Morphine Drugs Market Segmentation

• 6.1. Global Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Dosage Forms
• 6.2. Global Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.3. Global Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Palliative Care
• Diarrhea Suppressant
• Anesthesia
• Cold And Cough Suppressant
• Other Applications
• 6.4. Global Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgical Centers
• Other End Users
• 6.5. Global Morphine Drugs Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine Sulfate Injection
• Morphine Hydrochloride Injection
• Morphine Extended Release Injection
• 6.6. Global Morphine Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets (Immediate-Release, Extended-Release)
• Oral Solution Or Syrup
• Oral Capsules (Extended-Release Capsules)
• 6.7. Global Morphine Drugs Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rectal Suppositories
• Transdermal Patches
• Sublingual Tablets Or Films

7. Morphine Drugs Market Regional And Country Analysis

• 7.1. Global Morphine Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Morphine Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Morphine Drugs Market

• 8.1. Asia-Pacific Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Morphine Drugs Market

• 9.1. China Morphine Drugs Market Overview
• 9.2. China Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Morphine Drugs Market

• 10.1. India Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Morphine Drugs Market

• 11.1. Japan Morphine Drugs Market Overview
• 11.2. Japan Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Morphine Drugs Market

• 12.1. Australia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Morphine Drugs Market

• 13.1. Indonesia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Morphine Drugs Market

• 14.1. South Korea Morphine Drugs Market Overview
• 14.2. South Korea Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Morphine Drugs Market

• 15.1. Western Europe Morphine Drugs Market Overview
• 15.2. Western Europe Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Morphine Drugs Market

• 16.1. UK Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Morphine Drugs Market

• 17.1. Germany Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Morphine Drugs Market

• 18.1. France Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Morphine Drugs Market

• 19.1. Italy Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Morphine Drugs Market

• 20.1. Spain Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Morphine Drugs Market

• 21.1. Eastern Europe Morphine Drugs Market Overview
• 21.2. Eastern Europe Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Morphine Drugs Market

• 22.1. Russia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Morphine Drugs Market

• 23.1. North America Morphine Drugs Market Overview
• 23.2. North America Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Morphine Drugs Market

• 24.1. USA Morphine Drugs Market Overview
• 24.2. USA Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Morphine Drugs Market

• 25.1. Canada Morphine Drugs Market Overview
• 25.2. Canada Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Morphine Drugs Market

• 26.1. South America Morphine Drugs Market Overview
• 26.2. South America Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Morphine Drugs Market

• 27.1. Brazil Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Morphine Drugs Market

• 28.1. Middle East Morphine Drugs Market Overview
• 28.2. Middle East Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Morphine Drugs Market

• 29.1. Africa Morphine Drugs Market Overview
• 29.2. Africa Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Morphine Drugs Market Competitive Landscape And Company Profiles

• 30.1. Morphine Drugs Market Competitive Landscape
• 30.2. Morphine Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Rusan Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Morphine Drugs Market Other Major And Innovative Companies

• 31.1. Daiichi Sankyo Company Limited
• 31.2. Sandoz AG
• 31.3. Viatris Inc.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Apotex Inc.
• 31.6. Hikma Pharmaceuticals PLC
• 31.7. Endo Pharmaceuticals Inc.
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. Johnson Matthey Fine Chemicals
• 31.10. Fresenius Kabi USA LLC
• 31.11. Delpharm SaS
• 31.12. Alvogen Inc.
• 31.13. Mallinckrodt Pharmaceuticals
• 31.14. Lannett Company
• 31.15. Mayne Pharma Group Limited

32. Global Morphine Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Morphine Drugs Market

34. Recent Developments In The Morphine Drugs Market

35. Morphine Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Morphine Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Morphine Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Morphine Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer